SULF2
Basic information
Region (hg38): 20:47656197-47786616
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SULF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 60 | 65 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 60 | 8 | 3 |
Variants in SULF2
This is a list of pathogenic ClinVar variants found in the SULF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-47661793-C-T | not specified | Uncertain significance (May 06, 2024) | ||
20-47661845-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
20-47661855-G-T | not specified | Uncertain significance (Dec 15, 2022) | ||
20-47663080-T-C | not specified | Uncertain significance (Jul 29, 2022) | ||
20-47663093-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
20-47663149-T-C | not specified | Uncertain significance (Jun 26, 2023) | ||
20-47663160-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
20-47663162-T-G | not specified | Uncertain significance (Jan 03, 2024) | ||
20-47663191-G-T | not specified | Uncertain significance (Dec 19, 2022) | ||
20-47663456-T-A | not specified | Uncertain significance (May 03, 2023) | ||
20-47663466-C-T | Likely benign (Jul 06, 2018) | |||
20-47663467-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
20-47663474-G-T | not specified | Uncertain significance (Feb 23, 2023) | ||
20-47663617-C-T | Likely benign (Jul 10, 2018) | |||
20-47664166-C-T | Benign (Jul 23, 2018) | |||
20-47664171-T-A | not specified | Uncertain significance (Jun 24, 2022) | ||
20-47664182-T-C | not specified | Likely benign (May 05, 2023) | ||
20-47664187-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
20-47665200-T-C | not specified | Uncertain significance (Mar 11, 2022) | ||
20-47665250-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
20-47665859-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
20-47665934-C-T | not specified | Uncertain significance (May 20, 2024) | ||
20-47665939-T-A | not specified | Uncertain significance (Jul 09, 2021) | ||
20-47666256-T-C | Benign (Jul 30, 2018) | |||
20-47666285-C-T | not specified | Uncertain significance (Apr 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SULF2 | protein_coding | protein_coding | ENST00000359930 | 20 | 130269 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0106 | 0.989 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.72 | 442 | 556 | 0.795 | 0.0000368 | 5733 |
Missense in Polyphen | 169 | 255.19 | 0.66225 | 2624 | ||
Synonymous | 0.255 | 225 | 230 | 0.979 | 0.0000166 | 1593 |
Loss of Function | 4.57 | 13 | 46.7 | 0.278 | 0.00000240 | 533 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000216 | 0.000210 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000333 | 0.000326 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.0000443 | 0.0000439 |
Middle Eastern | 0.000333 | 0.000326 |
South Asian | 0.000205 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity. It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin.;
Intolerance Scores
- loftool
- 0.0167
- rvis_EVS
- -1.59
- rvis_percentile_EVS
- 3.08
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.510
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.665
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sulf2
- Phenotype
- muscle phenotype; craniofacial phenotype; cellular phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; renal/urinary system phenotype; skeleton phenotype; embryo phenotype; respiratory system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- kidney development;chondrocyte development;glomerular filtration;response to wounding;positive regulation of vascular endothelial growth factor production;esophagus smooth muscle contraction;positive regulation of Wnt signaling pathway;heparan sulfate proteoglycan metabolic process;glomerular basement membrane development;glial cell-derived neurotrophic factor receptor signaling pathway;negative regulation of fibroblast growth factor receptor signaling pathway;embryonic skeletal system development;cartilage development;bone development;innervation;positive regulation of canonical Wnt signaling pathway;liver regeneration;regulation of hepatocyte proliferation
- Cellular component
- extracellular space;endoplasmic reticulum;Golgi stack;plasma membrane;cell surface
- Molecular function
- arylsulfatase activity;calcium ion binding;glycosaminoglycan binding;N-acetylglucosamine-6-sulfatase activity